Support By : Li-lab
PATHWAY_NAME | REACTOME_ID | KEGG_ID | DRUG_NAME | PUBCHEM_CID | Datasource |
---|---|---|---|---|---|
ECM-receptor interaction | R-HSA-373711 | map04512 | meclofenoxate | 3759 | drug-path |
Gap junction | R-HSA-190861 | map04540 | meclofenoxate | 3759 | drug-path |
GnRH signaling pathway | R-HSA-168638 | map04912 | meclofenoxate | 3759 | drug-path |
Neuroactive ligand-receptor interaction | R-HSA-5632681 | map04080 | meclofenoxate | 3759 | drug-path |
Olfactory transduction | R-HSA-9751605 | map04740 | meclofenoxate | 3759 | drug-path |
Systemic lupus erythematosus | R-HSA-977105 | map05322 | meclofenoxate | 3759 | drug-path |
Olfactory transduction | R-HSA-9751605 | map04740 | levonorgestrel | 13109 | drug-path |
ECM-receptor interaction | R-HSA-373711 | map04512 | levonorgestrel | 13109 | drug-path |
Neuroactive ligand-receptor interaction | R-HSA-5632681 | map04080 | levonorgestrel | 13109 | drug-path |
Antigen processing and presentation | R-HSA-1236975 | map04612 | levonorgestrel | 13109 | drug-path |
Apoptosis | R-HSA-109581 | map04210 | levonorgestrel | 13109 | drug-path |
p53 signaling pathway | R-HSA-168638 | map04115 | levonorgestrel | 13109 | drug-path |
Calcium signaling pathway | R-HSA-381753 | map04020 | levonorgestrel | 13109 | drug-path |
Colorectal cancer | R-HSA-4791275 | map05210 | levonorgestrel | 13109 | drug-path |
Vascular smooth muscle contraction | R-HSA-445355 | map04270 | levonorgestrel | 13109 | drug-path |
PPAR signaling pathway | R-HSA-168638 | map03320 | tetrandrine | 1794427 | drug-path |
Pathways in cancer | R-HSA-9824443 | map05200 | tetrandrine | 1794427 | drug-path |
Huntington's disease | R-HSA-1643685 | 0 | tetrandrine | 1794427 | drug-path |
Olfactory transduction | R-HSA-9751605 | map04740 | tetrandrine | 1794427 | drug-path |
Focal adhesion | R-HSA-354113 | map04510 | tetrandrine | 1794427 | drug-path |